Keeren Shah - 16 May 2022 Form 3 Insider Report for OKYO Pharma Ltd (OKYO)

Role
Chief Financial Officer
Signature
/s/ Keeren Shah
Issuer symbol
OKYO
Transactions as of
16 May 2022
Net transactions value
$0
Form type
3
Filing time
16 May 2022, 17:53:30 UTC
Previous filing
09 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OKYO Option (right to buy) 16 May 2022 Ordinary Shares 300,000 $0.2025 Direct F1
holding OKYO Option (right to buy) 16 May 2022 Ordinary Shares 500,000 $0.0640 Direct F2
holding OKYO Option (right to buy) 16 May 2022 Ordinary Shares 150,000 $0.1045 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% will vest each year on August 1, beginning on August 2, 2020.
F2 25% will vest each year on August 1, beginning on August 31, 2021.
F3 Vest in equal amounts over three years beginning on January 31, 2022.